Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Ophthalmology

  Free Subscription


Articles published in Curr Opin Ophthalmol

Retrieve available abstracts of 197 articles:
HTML format



Single Articles


    March 2024
  1. PHILLIPS M, Chaudhary V
    Understanding network meta-analysis methodology for the ophthalmologist.
    Curr Opin Ophthalmol. 2024 Mar 15. doi: 10.1097/ICU.0000000000001048.
    PubMed     Abstract available


  2. HAMMELEF E, Rapuano CJ, Benedetto DA, Syed ZA, et al
    New forays into measurement of ocular biomechanics.
    Curr Opin Ophthalmol. 2024 Mar 14. doi: 10.1097/ICU.0000000000001032.
    PubMed     Abstract available


  3. GARG AK, Scott AW
    Systemic medications for sickle cell disease and potential applications for sickle cell retinopathy.
    Curr Opin Ophthalmol. 2024 Mar 11. doi: 10.1097/ICU.0000000000001041.
    PubMed     Abstract available


  4. BERKOWITZ ST, Finn AP
    Gene therapy for age-related macular degeneration: potential, feasibility, and pitfalls.
    Curr Opin Ophthalmol. 2024 Mar 5. doi: 10.1097/ICU.0000000000001043.
    PubMed     Abstract available


    February 2024
  5. KADONOSONO K, Inoue M, Yanagi Y
    Retinal arterial and vein occlusion: is surgery ever indicated?
    Curr Opin Ophthalmol. 2024 Feb 29. doi: 10.1097/ICU.0000000000001045.
    PubMed     Abstract available


  6. VAKHARIA P, Eichenbaum D
    Geographic atrophy: current and future therapeutic agents and practical considerations for retinal specialists.
    Curr Opin Ophthalmol. 2024 Feb 29. doi: 10.1097/ICU.0000000000001046.
    PubMed     Abstract available


  7. SHAH S, Chou B, Patel M, Watane A, et al
    Review and analysis of history and utilization of pneumatic retinopexy after pneumatic retinopexy versus vitrectomy for the management of primary rhegmatogenous retinal detachment outcomes randomized trial (PIVOT).
    Curr Opin Ophthalmol. 2024 Feb 16. doi: 10.1097/ICU.0000000000001039.
    PubMed     Abstract available


  8. MANDAVA NK, Kuriyan AE, Ho AC, Hsu J, et al
    Enhanced durability and evolution of retreatment criteria of intravitreal antivascular endothelial growth factor agents for diabetic macular edema.
    Curr Opin Ophthalmol. 2024 Feb 1. doi: 10.1097/ICU.0000000000001037.
    PubMed     Abstract available


    January 2024
  9. PEREZ AM, Neag E, Sridhar J, Williams BK Jr, et al
    Weight loss, bariatric surgery, and novel antidiabetic drugs effects on diabetic retinopathy: a review.
    Curr Opin Ophthalmol. 2024 Jan 31. doi: 10.1097/ICU.0000000000001038.
    PubMed     Abstract available


  10. YALLA GR, Kuriyan AE
    Cell therapy for retinal disease.
    Curr Opin Ophthalmol. 2024 Jan 25. doi: 10.1097/ICU.0000000000001034.
    PubMed     Abstract available


  11. MADADI Y, Delsoz M, Khouri AS, Boland M, et al
    Applications of artificial intelligence-enabled robots and chatbots in ophthalmology: recent advances and future trends.
    Curr Opin Ophthalmol. 2024 Jan 23. doi: 10.1097/ICU.0000000000001035.
    PubMed     Abstract available


  12. JO JJ, Pasquale LR
    Recent developments of telemedicine in glaucoma.
    Curr Opin Ophthalmol. 2024 Jan 19. doi: 10.1097/ICU.0000000000001019.
    PubMed     Abstract available


  13. HANIF AM, Jian Y, Young BK, Campbell JP, et al
    Implementation of optical coherence tomography in retinopathy of prematurity screening.
    Curr Opin Ophthalmol. 2024 Jan 12. doi: 10.1097/ICU.0000000000001030.
    PubMed     Abstract available


  14. NOWROUZI A, Alio JL
    Immediately sequential bilateral cataract surgery.
    Curr Opin Ophthalmol. 2024;35:17-22.
    PubMed     Abstract available


  15. LIEU AC, Afshari NA
    Patient experiences and satisfaction with cataract surgery.
    Curr Opin Ophthalmol. 2024;35:1-3.
    PubMed    


  16. PATEL SB, Heier JS, Chaudhary V, Wykoff CC, et al
    Treatment of geographic atrophy: an update on data related to pegcetacoplan.
    Curr Opin Ophthalmol. 2024;35:64-72.
    PubMed     Abstract available


    December 2023
  17. RODRIGUEZ-MARTINEZ AC, Wawrzynski J, Henderson RH
    Intravitreal enzyme replacement for inherited retinal diseases.
    Curr Opin Ophthalmol. 2023 Dec 27. doi: 10.1097/ICU.0000000000001029.
    PubMed     Abstract available


  18. LAM BL
    Leber hereditary optic neuropathy gene therapy.
    Curr Opin Ophthalmol. 2023 Dec 21. doi: 10.1097/ICU.0000000000001028.
    PubMed     Abstract available


  19. BORRAS T, Stepankoff M, Danias J
    Genes as drugs for glaucoma: latest advances.
    Curr Opin Ophthalmol. 2023 Dec 21. doi: 10.1097/ICU.0000000000001025.
    PubMed     Abstract available


  20. LEVIN AM, Sheybani A
    Glaucoma surgical procedures under development.
    Curr Opin Ophthalmol. 2023 Dec 15. doi: 10.1097/ICU.0000000000001020.
    PubMed     Abstract available


  21. REINSTEIN DZ, MacGregor C, Archer TJ, Gupta R, et al
    A review of posterior chamber phakic intraocular lenses.
    Curr Opin Ophthalmol. 2023 Dec 7. doi: 10.1097/ICU.0000000000001018.
    PubMed     Abstract available


    November 2023
  22. CORREIA BARAO R, Hemelings R, Abegao Pinto L, Pazos M, et al
    Artificial intelligence for glaucoma: state of the art and future perspectives.
    Curr Opin Ophthalmol. 2023 Nov 30. doi: 10.1097/ICU.0000000000001022.
    PubMed     Abstract available


  23. SABHARWAL J, Garg AK, Ramulu PY
    How much does cataract surgery contribute to intraocular pressure lowering?
    Curr Opin Ophthalmol. 2023 Nov 30. doi: 10.1097/ICU.0000000000001021.
    PubMed     Abstract available


  24. SARNICOLA E, Sarnicola C, De Bernardo M, Rosa N, et al
    Cataract surgery in setting of ocular surface disease.
    Curr Opin Ophthalmol. 2023 Nov 28. doi: 10.1097/ICU.0000000000001024.
    PubMed     Abstract available


  25. MAHMOUDINEZHAD G, Meller L, Moghimi S
    Impact of smoking on glaucoma.
    Curr Opin Ophthalmol. 2023 Nov 28. doi: 10.1097/ICU.0000000000001023.
    PubMed     Abstract available


  26. TING DS, Gatinel D, Ang M
    Cataract surgery after corneal refractive surgery: preoperative considerations and management.
    Curr Opin Ophthalmol. 2023 Nov 14. doi: 10.1097/ICU.0000000000001006.
    PubMed     Abstract available


  27. NARANG R, Agarwal A
    Refractive cataract surgery.
    Curr Opin Ophthalmol. 2023 Nov 14. doi: 10.1097/ICU.0000000000001005.
    PubMed     Abstract available


  28. BUONSANTI D, Raimundo M, Findl O
    Online intraocular lens calculation.
    Curr Opin Ophthalmol. 2023 Nov 6. doi: 10.1097/ICU.0000000000001014.
    PubMed     Abstract available


  29. BARQUET-PIZA V, Siegfried CJ
    Understanding racial disparities of glaucoma.
    Curr Opin Ophthalmol. 2023 Nov 6. doi: 10.1097/ICU.0000000000001017.
    PubMed     Abstract available


  30. JUN JH, Lieu A, Afshari NA
    Light adjustable intraocular lenses in cataract surgery: considerations.
    Curr Opin Ophthalmol. 2023 Nov 3. doi: 10.1097/ICU.0000000000001015.
    PubMed     Abstract available


  31. CIOCIOLA EC, Fernandez E, Kaufmann M, Klifto MR, et al
    Future directions of glaucoma treatment: emerging gene, neuroprotection, nanomedicine, stem cell, and vascular therapies.
    Curr Opin Ophthalmol. 2023 Nov 2. doi: 10.1097/ICU.0000000000001016.
    PubMed     Abstract available


  32. DE LA PAZ M, Tsai LM
    Outcomes and predictive factors in multifocal and extended depth of focus intraocular lens implantation.
    Curr Opin Ophthalmol. 2023 Nov 2. doi: 10.1097/ICU.0000000000001013.
    PubMed     Abstract available


  33. KHIEU C, Chanthan D
    Novel approach to Behcet's disease in the era of biologic agents.
    Curr Opin Ophthalmol. 2023;34:535-542.
    PubMed     Abstract available


  34. SUBRAMANIAN PS, Cho RI, Kahana A
    Efficacy of teprotumumab therapy in patients with long-duration thyroid eye disease.
    Curr Opin Ophthalmol. 2023;34:487-492.
    PubMed     Abstract available


  35. MANOHAR D, Shtein RM
    Update on pharmacotherapy for dry eye.
    Curr Opin Ophthalmol. 2023;34:550-554.
    PubMed     Abstract available


    October 2023
  36. LEE B, Afshari NA, Shaw PX
    Oxidative stress and antioxidants in cataract development.
    Curr Opin Ophthalmol. 2023 Oct 27. doi: 10.1097/ICU.0000000000001009.
    PubMed     Abstract available


  37. LIEU AC, Jun JH, Afshari NA
    Intracameral antibiotics during cataract surgery: efficacy, safety, and cost-benefit considerations.
    Curr Opin Ophthalmol. 2023 Oct 26. doi: 10.1097/ICU.0000000000001010.
    PubMed     Abstract available


  38. BERGERON E, Bouffard MA
    Evidence-based management of optic neuritis.
    Curr Opin Ophthalmol. 2023 Oct 17. doi: 10.1097/ICU.0000000000001007.
    PubMed     Abstract available


  39. RASOOL N
    Ophthalmic manifestations of Whipple's disease.
    Curr Opin Ophthalmol. 2023 Oct 16. doi: 10.1097/ICU.0000000000000989.
    PubMed     Abstract available


  40. SAVAGE DE, Pantanelli SM
    An update on intraocular lens power calculations in eyes with previous laser refractive surgery.
    Curr Opin Ophthalmol. 2023 Oct 12. doi: 10.1097/ICU.0000000000001004.
    PubMed     Abstract available


    September 2023
  41. POONJA S, Costello F
    Neuro-ophthalmic manifestations of autoimmune disorders: diagnostic pearls & pitfalls.
    Curr Opin Ophthalmol. 2023 Sep 21. doi: 10.1097/ICU.0000000000001001.
    PubMed     Abstract available


  42. CHOO CH, Gonzales J, Shantha JG
    Anxiety and depression in patients with uveitis: a comprehensive review of observational studies.
    Curr Opin Ophthalmol. 2023 Sep 8. doi: 10.1097/ICU.0000000000000999.
    PubMed     Abstract available


  43. WENG CY, Sridhar J
    Challenges and controversies in ophthalmology in 2023.
    Curr Opin Ophthalmol. 2023;34:361-362.
    PubMed    


    August 2023
  44. MILNER DC, Subramanian PS
    Insights into spaceflight-associated neuro-ocular syndrome with review of intraocular and orbital findings.
    Curr Opin Ophthalmol. 2023 Aug 31. doi: 10.1097/ICU.0000000000001000.
    PubMed     Abstract available


  45. RACHAPUDI SS, Laylani NA, Davila-Siliezar PA, Lee AG, et al
    Neuro-ophthalmic manifestations of Ehlers-Danlos syndrome.
    Curr Opin Ophthalmol. 2023 Aug 31. doi: 10.1097/ICU.0000000000001002.
    PubMed     Abstract available


  46. TOFADE TO, Chwalisz BK
    Neuro-ophthalmic complications of varicella-zoster virus.
    Curr Opin Ophthalmol. 2023 Aug 22. doi: 10.1097/ICU.0000000000000996.
    PubMed     Abstract available


  47. GROSSMAN SN, Rucker JC
    Opsoclonus and ocular flutter: evaluation and management.
    Curr Opin Ophthalmol. 2023 Aug 22. doi: 10.1097/ICU.0000000000000998.
    PubMed     Abstract available


  48. MILLER HV, Cao AA, McClelland CM, Lee MS, et al
    Linezolid optic neuropathy.
    Curr Opin Ophthalmol. 2023 Aug 22. doi: 10.1097/ICU.0000000000000995.
    PubMed     Abstract available


  49. BATES B, Crowell EL
    Ophthalmic manifestations of tuberculosis.
    Curr Opin Ophthalmol. 2023 Aug 21. doi: 10.1097/ICU.0000000000000991.
    PubMed     Abstract available


  50. NASSISI M, Mainetti C, Aretti A, Sperti A, et al
    Ocular features in Williams-Beuren syndrome: a review of the literature.
    Curr Opin Ophthalmol. 2023 Aug 18. doi: 10.1097/ICU.0000000000000990.
    PubMed     Abstract available


  51. KONGWATTANANON W, Pothikamjorn T, Somkijrungroj T
    Posterior segment manifestations of ocular metastasis.
    Curr Opin Ophthalmol. 2023 Aug 10. doi: 10.1097/ICU.0000000000000988.
    PubMed     Abstract available


    July 2023
  52. NATH S, Rahimy E, Kras A, Korot E, et al
    Toward safer ophthalmic artificial intelligence via distributed validation on real-world data.
    Curr Opin Ophthalmol. 2023 Jul 18. doi: 10.1097/ICU.0000000000000986.
    PubMed     Abstract available


  53. TING DSW, Humayun MS, Huang SS
    Gaps and future of human-centered artificial intelligence in ophthalmology: Future Vision Forum consensus statement.
    Curr Opin Ophthalmol. 2023 Jul 18. doi: 10.1097/ICU.0000000000000984.
    PubMed     Abstract available


  54. RUAMVIBOONSUK P, Ruamviboonsuk V, Tiwari R
    Recent evidence of economic evaluation of artificial intelligence in ophthalmology.
    Curr Opin Ophthalmol. 2023 Jul 18. doi: 10.1097/ICU.0000000000000987.
    PubMed     Abstract available


  55. TAN TF, Dai P, Zhang X, Jin L, et al
    Explainable artificial intelligence in ophthalmology.
    Curr Opin Ophthalmol. 2023 Jul 3. doi: 10.1097/ICU.0000000000000983.
    PubMed     Abstract available


  56. NORTHEY LC, Moloney G
    Role of descemet's stripping without keratoplasty in management of endothelial disease.
    Curr Opin Ophthalmol. 2023;34:348-353.
    PubMed     Abstract available


  57. KAUFMAN R, Jun AS
    Recent advances in cell-based regenerative therapies for corneal disease.
    Curr Opin Ophthalmol. 2023;34:303-310.
    PubMed     Abstract available


  58. ONG LF, Oh A, Yi JK, Gu JS, et al
    Refractive lens exchange - who is getting it, what are they getting, how are they doing?
    Curr Opin Ophthalmol. 2023;34:280-289.
    PubMed     Abstract available


  59. TRAN LT, Li JY
    The role of eye banking with cell-based therapies.
    Curr Opin Ophthalmol. 2023;34:334-338.
    PubMed     Abstract available


  60. ONISHI AC, Lee-Choi C, Marvasti AH
    Topography-guided excimer laser ablation.
    Curr Opin Ophthalmol. 2023;34:296-302.
    PubMed     Abstract available


    June 2023
  61. CALLAWAY NF, Cunningham ET Jr
    Alternative career paths for ophthalmologists.
    Curr Opin Ophthalmol. 2023 Jun 20. doi: 10.1097/ICU.0000000000000975.
    PubMed     Abstract available


  62. KOSEOGLU ND, Correa ZM, Liu TYA
    Artificial intelligence for ocular oncology.
    Curr Opin Ophthalmol. 2023 Jun 16. doi: 10.1097/ICU.0000000000000982.
    PubMed     Abstract available


  63. CHOU YB, Kale AU, Lanzetta P, Aslam T, et al
    Current status and practical considerations of artificial intelligence use in screening and diagnosing retinal diseases: Vision Academy retinal expert consensus.
    Curr Opin Ophthalmol. 2023 Jun 16. doi: 10.1097/ICU.0000000000000979.
    PubMed     Abstract available


  64. DANESE C, Kale AU, Aslam T, Barratt J, et al
    The impact of artificial intelligence on retinal disease management: Vision Academy retinal expert consensus.
    Curr Opin Ophthalmol. 2023 Jun 13. doi: 10.1097/ICU.0000000000000980.
    PubMed     Abstract available


    May 2023
  65. ZHU JM, Aderman CM
    Private equity in ophthalmology: taking the long view.
    Curr Opin Ophthalmol. 2023 May 24. doi: 10.1097/ICU.0000000000000976.
    PubMed     Abstract available


  66. EHLERS JP, Baraona J
    Use of physician extenders in ophthalmology: pros.
    Curr Opin Ophthalmol. 2023 May 4. doi: 10.1097/ICU.0000000000000972.
    PubMed     Abstract available


  67. TIMTIM E, Weng CY, Finn AP
    Safety of recent ophthalmic drugs and devices for wet macular degeneration.
    Curr Opin Ophthalmol. 2023 May 4. doi: 10.1097/ICU.0000000000000974.
    PubMed     Abstract available


  68. LIN BR, Sridhar J, Uhler T
    The ophthalmology residency match: a new era.
    Curr Opin Ophthalmol. 2023 May 4. doi: 10.1097/ICU.0000000000000973.
    PubMed     Abstract available


  69. AGUWA UT, Williams BK Jr, Woreta FA
    Diversity, equity and inclusion in ophthalmology.
    Curr Opin Ophthalmol. 2023 May 4. doi: 10.1097/ICU.0000000000000970.
    PubMed     Abstract available


  70. GARG SJ, Hsu J
    Translational ophthalmology 2023.
    Curr Opin Ophthalmol. 2023;34:243-244.
    PubMed    


  71. CLEVENGER L, Rachitskaya A
    Identifying geographic atrophy.
    Curr Opin Ophthalmol. 2023;34:195-202.
    PubMed     Abstract available


    April 2023
  72. HAFEZI F, Torres-Netto EA, Hillen M
    Expanding indications for corneal cross-linking.
    Curr Opin Ophthalmol. 2023 Apr 26. doi: 10.1097/ICU.0000000000000967.
    PubMed     Abstract available


  73. HICKS PM, Armstrong ML, Woodward MA
    Current social determinants of health and social risk factors in conditions of the cornea: a scoping review.
    Curr Opin Ophthalmol. 2023 Apr 26. doi: 10.1097/ICU.0000000000000960.
    PubMed     Abstract available


  74. TRAN TM, Hou JH
    Clinical applications of bioengineered tissue-cellular products for management of corneal diseases.
    Curr Opin Ophthalmol. 2023 Apr 26. doi: 10.1097/ICU.0000000000000961.
    PubMed     Abstract available


  75. DOUGLAS VP, Douglas KAA, Torun N
    Optical coherence tomography angiography in neuro-ophthalmology.
    Curr Opin Ophthalmol. 2023 Apr 19. doi: 10.1097/ICU.0000000000000955.
    PubMed     Abstract available


    March 2023
  76. HEIN JC, Tauber J, Shrivastava A
    Refractive surgery for the glaucoma suspect.
    Curr Opin Ophthalmol. 2023 Mar 30. doi: 10.1097/ICU.0000000000000954.
    PubMed     Abstract available


  77. LEVIN HJ, Mehta MS, Storey PP, Patel SN, et al
    Endophthalmitis following cataract surgery: visual outcomes, microbial spectrum and complications.
    Curr Opin Ophthalmol. 2023 Mar 21. doi: 10.1097/ICU.0000000000000951.
    PubMed     Abstract available


  78. DEBOER CMT, Agrawal R, Rahimy E
    Novel oral medications for retinal disease: an update on clinical development.
    Curr Opin Ophthalmol. 2023 Mar 21. doi: 10.1097/ICU.0000000000000948.
    PubMed     Abstract available


  79. JUSTIN GA, Girach A, Maldonado RS
    Antisense oligonucleotide therapy for proline-23-histidine autosomal dominant retinitis pigmentosa.
    Curr Opin Ophthalmol. 2023 Mar 15. doi: 10.1097/ICU.0000000000000947.
    PubMed     Abstract available


  80. PANDIT S, Ho AC, Yonekawa Y
    Recent advances in the management of proliferative diabetic retinopathy.
    Curr Opin Ophthalmol. 2023 Mar 6. doi: 10.1097/ICU.0000000000000946.
    PubMed     Abstract available


  81. SHAH S, Markatia Z, Watane A, Feldman A, et al
    Do published trial results influence physician prescribing patterns? Intravitreal antivascular endothelial growth factor usage by the United States Ophthalmologists before and after Protocol T study.
    Curr Opin Ophthalmol. 2023 Mar 2. doi: 10.1097/ICU.0000000000000944.
    PubMed     Abstract available


  82. STARR MR, Ryan EH, Yonekawa Y
    Primary Retinal Detachment Outcomes Study: summary of reports number 1 to number 18.
    Curr Opin Ophthalmol. 2023 Mar 2. doi: 10.1097/ICU.0000000000000942.
    PubMed     Abstract available


  83. MULPURI L, Sridhar J, Goyal H, Tonk R, et al
    The relationship between dietary patterns and ophthalmic disease.
    Curr Opin Ophthalmol. 2023 Mar 2. doi: 10.1097/ICU.0000000000000943.
    PubMed     Abstract available


  84. SEOW WH, Lim CHL, Lim BXH, Lim DK, et al
    Uveitis and glaucoma: a look at present day surgical options.
    Curr Opin Ophthalmol. 2023;34:152-161.
    PubMed     Abstract available


  85. CHEN X, Shen T
    Advances in innovative delivery systems for antiglaucoma drugs.
    Curr Opin Ophthalmol. 2023;34:123-128.
    PubMed     Abstract available


  86. HOVANESIAN J, Singh IP, Bauskar A, Vantipalli S, et al
    Identifying and addressing common contributors to nonadherence with ophthalmic medical therapy.
    Curr Opin Ophthalmol. 2023;34.
    PubMed     Abstract available


    January 2023
  87. SHI A, Salim S
    Vision rehabilitation in glaucoma patients.
    Curr Opin Ophthalmol. 2023 Jan 14. doi: 10.1097/ICU.0000000000000930.
    PubMed     Abstract available


  88. KHODEIRY M, Sayed MS
    New glaucoma drainage implants available to glaucoma surgeons.
    Curr Opin Ophthalmol. 2023 Jan 14. doi: 10.1097/ICU.0000000000000936.
    PubMed     Abstract available


  89. LEE JY, Knight RJ, Deng SX
    Future regenerative therapies for corneal disease.
    Curr Opin Ophthalmol. 2023 Jan 6. doi: 10.1097/ICU.0000000000000938.
    PubMed     Abstract available


  90. SARNICOLA E, Sarnicola C, Sarnicola V
    Dilation devices in cataract surgery.
    Curr Opin Ophthalmol. 2023;34:71-77.
    PubMed     Abstract available


  91. MELVANI R, Farid M
    The evidence of implanting a different intraocular lens in each eye.
    Curr Opin Ophthalmol. 2023;34:36-40.
    PubMed     Abstract available


  92. LEE BS, Chang DF
    Chopping techniques in cataract surgery.
    Curr Opin Ophthalmol. 2023;34:32-35.
    PubMed     Abstract available


  93. BHANDARI S, Chew EY
    Cataract surgery and the risk of progression of macular degeneration.
    Curr Opin Ophthalmol. 2023;34:27-31.
    PubMed     Abstract available


  94. LEE BJ, Afshari NA
    Advances in drug therapy and delivery for cataract treatment.
    Curr Opin Ophthalmol. 2023;34:3-8.
    PubMed     Abstract available


  95. BUCHHOLZ RD, Afshari NA
    Editorial: Cataract surgery: Unique Populations, and Surgical Challenges.
    Curr Opin Ophthalmol. 2023;34:1-2.
    PubMed    


  96. ELHUSSEINY AM, Salim S
    Cataract surgery in myopic eyes.
    Curr Opin Ophthalmol. 2023;34:64-70.
    PubMed     Abstract available


  97. KAUFMAN AR, Pineda R 2nd
    Intraoperative aberrometry: an update on applications and outcomes.
    Curr Opin Ophthalmol. 2023;34:48-57.
    PubMed     Abstract available


    December 2022
  98. HUBBARD DC, Cox P, Redd TK
    Assistive applications of artificial intelligence in ophthalmology.
    Curr Opin Ophthalmol. 2022 Dec 30. doi: 10.1097/ICU.0000000000000939.
    PubMed     Abstract available


  99. GUTIERREZ A, Chen TC
    Artificial intelligence in glaucoma: posterior segment optical coherence tomography.
    Curr Opin Ophthalmol. 2022 Dec 28. doi: 10.1097/ICU.0000000000000934.
    PubMed     Abstract available


  100. CHANG CJ, Winn BJ
    Perturbations of the ocular surface microbiome and their effect on host immune function.
    Curr Opin Ophthalmol. 2022 Dec 23. doi: 10.1097/ICU.0000000000000931.
    PubMed     Abstract available


    November 2022
  101. JODY N, Santana M, Rudell J
    Pediatric cataract surgery: considerations and updates in diagnosis and management.
    Curr Opin Ophthalmol. 2022 Nov 23. doi: 10.1097/ICU.0000000000000918.
    PubMed     Abstract available


  102. CHEN RI, Gedde SJ
    Assessment of visual field progression in glaucoma.
    Curr Opin Ophthalmol. 2022 Nov 16. pii: 00055735-990000000-00063.
    PubMed     Abstract available


  103. RADCLIFFE N
    The case for standalone micro-invasive glaucoma surgery: rethinking the role of surgery in the glaucoma treatment paradigm.
    Curr Opin Ophthalmol. 2022 Nov 15. pii: 00055735-990000000-00062.
    PubMed     Abstract available


  104. ELHUSSEINY AM, Sallam AB
    Cataract surgery in adult eyes with short axial length.
    Curr Opin Ophthalmol. 2022 Nov 15. pii: 00055735-990000000-00060.
    PubMed     Abstract available


  105. YING S, Sidoti PA, Panarelli JF
    Risk factors and management of choroidal effusions.
    Curr Opin Ophthalmol. 2022 Nov 10. doi: 10.1097/ICU.0000000000000929.
    PubMed     Abstract available


  106. GEDDE SJ, Vinod K, Prum BE Jr
    Results from the Primary Tube Versus Trabeculectomy Study and translation to clinical practice.
    Curr Opin Ophthalmol. 2022 Nov 10. doi: 10.1097/ICU.0000000000000928.
    PubMed     Abstract available


  107. MEIER-GIBBONS F, Toteberg-Harms M
    Follow-up studies of the classical landmark studies in Glaucoma.
    Curr Opin Ophthalmol. 2022 Nov 8. doi: 10.1097/ICU.0000000000000926.
    PubMed     Abstract available


  108. LIEBMAN DL, Wen JC, Shen LQ
    Detecting disease progression in mild, moderate and severe glaucoma.
    Curr Opin Ophthalmol. 2022 Nov 8. doi: 10.1097/ICU.0000000000000925.
    PubMed     Abstract available


  109. SUN JA, Manz SN, Shen LQ
    Glaucoma management in patients with penetrating keratoplasty or keratoprosthesis.
    Curr Opin Ophthalmol. 2022 Nov 8. doi: 10.1097/ICU.0000000000000924.
    PubMed     Abstract available


  110. AREF AA, Parker PR, Chen MY
    Microinvasive glaucoma surgeries: critical summary of clinical trial data with and without phacoemulsification.
    Curr Opin Ophthalmol. 2022 Nov 8. doi: 10.1097/ICU.0000000000000923.
    PubMed     Abstract available


  111. SIVAKUMAR RR
    Ocular leptospirosis: lack of awareness among ophthalmologists and challenges in diagnosis.
    Curr Opin Ophthalmol. 2022;33:532-542.
    PubMed     Abstract available


  112. REICHSTEIN D, Brock A, Lietman C, McKean M, et al
    Treatment of metastatic uveal melanoma in 2022: improved treatment regimens and improved prognosis.
    Curr Opin Ophthalmol. 2022;33:585-590.
    PubMed     Abstract available


  113. LEET MP, Bear MF, Gaier ED
    Metaplasticity: a key to visual recovery from amblyopia in adulthood?
    Curr Opin Ophthalmol. 2022;33:512-518.
    PubMed     Abstract available


  114. CHAPMAN JJ, Heidary G, Gise R
    An overview of peripapillary hyperreflective ovoid mass-like structures.
    Curr Opin Ophthalmol. 2022;33:494-500.
    PubMed     Abstract available


  115. SAITAKIS G, Chwalisz BK
    Optic perineuritis.
    Curr Opin Ophthalmol. 2022;33:519-524.
    PubMed     Abstract available


  116. ISLAM YFK, Khurshid SG
    Incontinentia pigmenti and the eye.
    Curr Opin Ophthalmol. 2022;33:525-531.
    PubMed     Abstract available


    October 2022
  117. GRZYBOWSKI A, Sidaraite A, Zemaitiene R
    Management of inflammation after the cataract surgery.
    Curr Opin Ophthalmol. 2022 Oct 21. pii: 00055735-990000000-00052.
    PubMed     Abstract available


  118. MOSHIRFAR M, Martin DJ, Jensen JL, Payne CJ, et al
    Light adjustable intraocular lenses: an updated platform for cataract surgery.
    Curr Opin Ophthalmol. 2022 Oct 17. pii: 00055735-990000000-00049.
    PubMed     Abstract available


    September 2022
  119. SPEKREIJSE LS, Nuijts RMMA
    An update on immediate sequential bilateral cataract surgery.
    Curr Opin Ophthalmol. 2022 Sep 29. pii: 00055735-990000000-00048.
    PubMed     Abstract available


  120. SURA AA, McCallum RM
    Peripheral ulcerative keratitis due to systemic diseases.
    Curr Opin Ophthalmol. 2022 Sep 20. pii: 00055735-990000000-00046.
    PubMed     Abstract available


  121. MOSHIRFAR M, Ziari M, Ronquillo YC
    Cataract surgery considerations in patients with prior history of keratoconus and ectasia.
    Curr Opin Ophthalmol. 2022 Sep 20. pii: 00055735-990000000-00045.
    PubMed     Abstract available


  122. SUTRA P, Pokawattana I
    Retinal vasculopathy following varicella zoster virus infection.
    Curr Opin Ophthalmol. 2022 Sep 19. pii: 00055735-990000000-00044.
    PubMed     Abstract available


  123. REDDY AK, Kolfenbach JR, Palestine AG
    Ocular manifestations of rheumatoid arthritis.
    Curr Opin Ophthalmol. 2022 Sep 19. pii: 00055735-990000000-00042.
    PubMed     Abstract available


  124. BHAT N, Bakaeva T
    Approach to the diagnosis and management of nutritional optic neuropathies.
    Curr Opin Ophthalmol. 2022 Sep 19. pii: 00055735-990000000-00043.
    PubMed     Abstract available


  125. DINKIN M, Sathi S
    Efferent neuro-ophthalmic complications of coronavirus disease 2019.
    Curr Opin Ophthalmol. 2022 Sep 14. pii: 00055735-990000000-00041.
    PubMed     Abstract available


  126. MOSHIRFAR M, Webster CR, Ronquillo YC
    Phakic intraocular lenses: an update and review for the treatment of myopia and myopic astigmatism in the United States.
    Curr Opin Ophthalmol. 2022;33:453-463.
    PubMed     Abstract available


  127. WONG DYL, Lam MC, Ran A, Cheung CY, et al
    Artificial intelligence in retinal imaging for cardiovascular disease prediction: current trends and future directions.
    Curr Opin Ophthalmol. 2022;33:440-446.
    PubMed     Abstract available


  128. PERSHING S, Lum F
    The American Academy of Ophthalmology IRIS Registry (Intelligent Research In Sight): current and future state of big data analytics.
    Curr Opin Ophthalmol. 2022;33:394-398.
    PubMed     Abstract available


  129. CHANG MA, Pearlman JA
    Private equity ownership of ophthalmology practices: how does it impact clinical research?
    Curr Opin Ophthalmol. 2022;33:368-372.
    PubMed     Abstract available


  130. BRILL D, Luo S, Sridhar J, Williams BK Jr, et al
    Private equity in ophthalmology: lessons from other specialties.
    Curr Opin Ophthalmol. 2022;33:352-361.
    PubMed     Abstract available


  131. SRIDHAR J, Weng CY
    Editorial: Private equity investment and ophthalmology: why the discussion matters.
    Curr Opin Ophthalmol. 2022;33:339-341.
    PubMed    


    August 2022
  132. DAVILA-SILIEZAR P, Carter M, Milea D, Lee AG, et al
    Leber hereditary optic neuropathy: new and emerging therapies.
    Curr Opin Ophthalmol. 2022 Aug 25. pii: 00055735-990000000-00035.
    PubMed     Abstract available


  133. RYU BU, Laylani NAR, Davila-Siliezar P, Lee AG, et al
    Rhino-orbital mucormycosis.
    Curr Opin Ophthalmol. 2022 Aug 25. pii: 00055735-990000000-00034.
    PubMed     Abstract available


  134. LEE SK, Lee MS
    Ocular neuromyotonia: a review of diagnosis and treatment.
    Curr Opin Ophthalmol. 2022 Aug 18. pii: 00055735-990000000-00032.
    PubMed     Abstract available


  135. BHATTI MT, Miller NR
    Post-cataract surgery optic neuropathy: a chronological narrative review of the literature and speculation on pathogenesis.
    Curr Opin Ophthalmol. 2022 Aug 18. pii: 00055735-990000000-00033.
    PubMed     Abstract available


    July 2022
  136. RUBY AJ, Williams GA
    Private equity in ophthalmology: differences between present versus past.
    Curr Opin Ophthalmol. 2022 Jul 16. pii: 00055735-990000000-00024.
    PubMed     Abstract available


  137. DEL PIERO J, Parikh R, Weng CY
    Driving forces and current trends in private equity acquisitions within ophthalmology.
    Curr Opin Ophthalmol. 2022 Jul 16. pii: 00055735-990000000-00021.
    PubMed     Abstract available


  138. PATEL S, Garner DC, Berkowitz ST, Sternberg P Jr, et al
    Implications of the presence of private equity in ophthalmology: an academic perspective.
    Curr Opin Ophthalmol. 2022 Jul 12. pii: 00055735-990000000-00014.
    PubMed     Abstract available


  139. PATIL AD, Biousse V, Newman NJ
    Artificial intelligence in ophthalmology: an insight into neurodegenerative disease.
    Curr Opin Ophthalmol. 2022 Jul 12. pii: 00055735-990000000-00013.
    PubMed     Abstract available


  140. SHAH CP, Wolfe JD
    How private equity achieves return on investment in ophthalmology.
    Curr Opin Ophthalmol. 2022 Jul 12. pii: 00055735-990000000-00019.
    PubMed     Abstract available


  141. KANG L, Ballouz D, Woodward MA
    Artificial intelligence and corneal diseases.
    Curr Opin Ophthalmol. 2022 Jul 12. pii: 00055735-990000000-00016.
    PubMed     Abstract available


  142. HALFPENNY W, Baxter SL
    Towards effective data sharing in ophthalmology: data standardization and data privacy.
    Curr Opin Ophthalmol. 2022 Jul 12. pii: 00055735-990000000-00015.
    PubMed     Abstract available


  143. HAKIM FE, He PC, Veldman PB
    Management of endothelial disease without keratoplasty.
    Curr Opin Ophthalmol. 2022;33:332-337.
    PubMed     Abstract available


  144. SIDDIQUI A, Chamberlain WD
    Descemet membrane endothelial keratoplasty in complex eyes.
    Curr Opin Ophthalmol. 2022;33:324-331.
    PubMed     Abstract available


  145. CHOI JH, Jeng BH
    Indications for keratoplasty in management of corneal ectasia.
    Curr Opin Ophthalmol. 2022;33:318-323.
    PubMed     Abstract available


  146. MUKHTAR S, Jhanji V
    Effects of systemic targeted immunosuppressive therapy on ocular surface.
    Curr Opin Ophthalmol. 2022;33:311-317.
    PubMed     Abstract available


  147. WANG Y, Jacobs DS
    Role of therapeutic contact lenses in management of corneal disease.
    Curr Opin Ophthalmol. 2022;33:306-310.
    PubMed     Abstract available


  148. DUGAN SP, Mian SI
    Impact of vaccination on keratoplasty.
    Curr Opin Ophthalmol. 2022;33:296-305.
    PubMed     Abstract available


  149. JEANG L, Tuli SS
    Therapy for contact lens-related ulcers.
    Curr Opin Ophthalmol. 2022;33:282-289.
    PubMed     Abstract available


  150. MEGHPARA BB, Lee JK, Rapuano CJ, Mian SI, et al
    Pilocarpine 1.25% and the changing landscape of presbyopia treatment.
    Curr Opin Ophthalmol. 2022;33:269-274.
    PubMed     Abstract available


  151. REINSTEIN DZ, Archer TJ, Vida RS
    Epithelial thickness mapping for corneal refractive surgery.
    Curr Opin Ophthalmol. 2022;33:258-268.
    PubMed     Abstract available


  152. TAUBER J, Kennedy T, Juthani V
    The preoperative management of meibomian gland dysfunction prior to corneal refractive surgery.
    Curr Opin Ophthalmol. 2022;33:251-257.
    PubMed     Abstract available


    June 2022
  153. TAUBER J, Kennedy T, Juthani V
    The preoperative management of meibomian gland dysfunction prior to corneal refractive surgery.
    Curr Opin Ophthalmol. 2022 Jun 28. pii: 00055735-990000000-00010.
    PubMed     Abstract available


  154. LI JY
    Advances in eye banking and corneal tissue processing.
    Curr Opin Ophthalmol. 2022 Jun 28. pii: 00055735-990000000-00005.
    PubMed     Abstract available


  155. WANG Y, Jacobs DS
    Role of therapeutic contact lenses in management of corneal disease.
    Curr Opin Ophthalmol. 2022 Jun 28. pii: 00055735-990000000-00009.
    PubMed     Abstract available


  156. REINSTEIN DZ, Archer TJ, Vida RS
    Epithelial thickness mapping for corneal refractive surgery.
    Curr Opin Ophthalmol. 2022 Jun 28. pii: 00055735-990000000-00007.
    PubMed     Abstract available


  157. MUKHTAR S, Jhanji V
    Effects of systemic targeted immunosuppressive therapy on ocular surface.
    Curr Opin Ophthalmol. 2022 Jun 28. pii: 00055735-990000000-00004.
    PubMed     Abstract available


  158. HUDSON J, Al-Khersan H, Carletti P, Miller D, et al
    Role of corneal biopsy in the management of infectious keratitis.
    Curr Opin Ophthalmol. 2022 Jun 16. pii: 00055735-990000000-00001.
    PubMed     Abstract available


  159. WONG EN, Mehta JS
    Cell therapy in corneal endothelial disease.
    Curr Opin Ophthalmol. 2022 Jun 15. pii: 00055735-990000000-00002.
    PubMed     Abstract available


    May 2022
  160. KUO BL, Singh RP
    Brolucizumab for the treatment of diabetic macular edema.
    Curr Opin Ophthalmol. 2022;33:167-173.
    PubMed     Abstract available


  161. SHAHLAEE A, Woeller CF, Philp NJ, Kuriyan AE, et al
    Translational and clinical advancements in management of proliferative vitreoretinopathy.
    Curr Opin Ophthalmol. 2022;33:219-227.
    PubMed     Abstract available


  162. RODRIGUEZ-LOPEZ V, Dorronsoro C
    Beyond traditional subjective refraction.
    Curr Opin Ophthalmol. 2022;33:228-234.
    PubMed     Abstract available


  163. HEIFERMAN MJ, Mahajan VB, Mruthyunjaya P
    Proteomics in uveal melanoma.
    Curr Opin Ophthalmol. 2022;33:202-210.
    PubMed     Abstract available


    March 2022
  164. ADAMIS AP, de Juan E Jr
    Development of the Port Delivery System with ranibizumab for neovascular age-related macular degeneration.
    Curr Opin Ophthalmol. 2022 Mar 9. pii: 00055735-900000000-98969.
    PubMed     Abstract available


  165. LIM JS, Hong M, Lam WST, Zhang Z, et al
    Novel technical and privacy-preserving technology for artificial intelligence in ophthalmology.
    Curr Opin Ophthalmol. 2022 Mar 9. pii: 00055735-900000000-98968.
    PubMed     Abstract available


  166. PATEL D, Patel SN, Chaudhary V, Garg SJ, et al
    Complications of intravitreal injections: 2022.
    Curr Opin Ophthalmol. 2022 Mar 9. pii: 00055735-900000000-98967.
    PubMed     Abstract available


  167. AREPALLI SR, Thomas AS
    Occlusive retinal vasculitis: novel insights into causes, pathogenesis and treatment.
    Curr Opin Ophthalmol. 2022 Mar 2. pii: 00055735-900000000-98972.
    PubMed     Abstract available


  168. LIGHT JG, Pyfer MS, Salabati M, Mahmoudzadeh R, et al
    Stellate nonhereditary idiopathic foveomacular retinoschisis and an approach to the differential diagnosis of macular star.
    Curr Opin Ophthalmol. 2022 Mar 2. pii: 00055735-900000000-98971.
    PubMed     Abstract available


  169. KALARN S, Le T, Rhee DJ
    The role of trabeculectomy in the era of minimally invasive glaucoma surgery.
    Curr Opin Ophthalmol. 2022;33:112-118.
    PubMed     Abstract available


    February 2022
  170. SOARES RR
    The evolving field of Big Data: understanding geographic information systems analysis and its transformative potential in ophthalmic research.
    Curr Opin Ophthalmol. 2022 Feb 25. pii: 00055735-900000000-98974.
    PubMed     Abstract available


  171. KASHANI AH
    Stem cell-derived retinal pigment epithelium transplantation in age-related macular degeneration: recent advances and challenges.
    Curr Opin Ophthalmol. 2022 Feb 23. pii: 00055735-900000000-98976.
    PubMed     Abstract available


  172. KHODEIRY MM, Liu X, Lee RK
    Clinical outcomes of slow-coagulation continuous-wave transscleral cyclophotocoagulation laser for treatment of glaucoma.
    Curr Opin Ophthalmol. 2022 Feb 23. pii: 00055735-900000000-98975.
    PubMed     Abstract available


  173. JAMMAL AA, Medeiros FA
    Corneal hysteresis: ready for prime time?
    Curr Opin Ophthalmol. 2022 Feb 21. pii: 00055735-900000000-98977.
    PubMed     Abstract available


  174. NADEEM U, Boachie-Mensah M, Zhang J, Skondra D, et al
    Gut microbiome and retinal diseases: an updated review.
    Curr Opin Ophthalmol. 2022 Feb 7. pii: 00055735-900000000-98978.
    PubMed     Abstract available


    January 2022
  175. SEAH I, Sng CCA, Ang M
    Endothelial cell loss associated with minimally invasive glaucoma surgery.
    Curr Opin Ophthalmol. 2022 Jan 17. pii: 00055735-900000000-98981.
    PubMed     Abstract available


  176. PETERSEN CA, Chen A, Chen PP
    How should we measure intraocular pressure in the era of coronavirus disease 2019? Balancing infectious risk, cleaning requirements, and accuracy.
    Curr Opin Ophthalmol. 2022 Jan 12. pii: 00055735-900000000-98982.
    PubMed     Abstract available


  177. ABBAS AA, Bu JJ, Chung J, Afshari NA, et al
    Recent developments in anterior capsulotomy for cataract surgery.
    Curr Opin Ophthalmol. 2022;33:47-52.
    PubMed     Abstract available


  178. BU JJ, Chung J, Afshari NA
    Efficient use of ultrasound in cataract surgery.
    Curr Opin Ophthalmol. 2022;33:41-46.
    PubMed     Abstract available


  179. CHUNG J, Bu JJ, Afshari NA
    Advancements in intraocular lens power calculation formulas.
    Curr Opin Ophthalmol. 2022;33:35-40.
    PubMed     Abstract available


  180. BU JJ, Afshari NA
    Editorial: advancing cataract surgery through innovation and methodology.
    Curr Opin Ophthalmol. 2022;33:1-2.
    PubMed    


  181. SALABATI M, Mahmoudzadeh R, Wakabayashi T, Hinkle JW, et al
    Indications for surgical management of retained lens fragments.
    Curr Opin Ophthalmol. 2022;33:15-20.
    PubMed     Abstract available


  182. PARK SSE, Wilkinson S, Mamalis N
    Dealing with floppy iris syndrome.
    Curr Opin Ophthalmol. 2022;33:3-8.
    PubMed     Abstract available


    December 2021
  183. SAFA BN, Wong CA, Ha J, Ethier CR, et al
    Glaucoma and biomechanics.
    Curr Opin Ophthalmol. 2021 Dec 24. pii: 00055735-900000000-98983.
    PubMed     Abstract available


  184. GUZMAN APARICIO MA, Chen TC
    New views on three-dimensional imaging technologies for glaucoma: an overview.
    Curr Opin Ophthalmol. 2021 Dec 3. pii: 00055735-900000000-98984.
    PubMed     Abstract available


    November 2021
  185. VENKATESWARAN N, Henderson BA
    Loose zonules in cataract surgery.
    Curr Opin Ophthalmol. 2021 Nov 15. pii: 00055735-900000000-98985.
    PubMed     Abstract available


  186. GO MS, Freedman SF
    Minimally invasive glaucoma surgery in childhood glaucoma.
    Curr Opin Ophthalmol. 2021 Nov 11. pii: 00055735-900000000-98986.
    PubMed     Abstract available


  187. MOSHIRFAR M, Huynh R, Ellis JH
    Cataract surgery and intraocular lens placement in patients with Fuchs corneal dystrophy: a review of the current literature.
    Curr Opin Ophthalmol. 2021 Nov 5. pii: 00055735-900000000-98987.
    PubMed     Abstract available


  188. ZHANG Y, Stewart JM
    Retinal and choroidal manifestations of COVID-19.
    Curr Opin Ophthalmol. 2021;32:536-540.
    PubMed     Abstract available


  189. KHONG EWC, Chan HHL, Watson SL, Lim LL, et al
    Pregnancy and the eye.
    Curr Opin Ophthalmol. 2021;32:527-535.
    PubMed     Abstract available


  190. JOYE A, Suhler E
    Vogt-Koyanagi-Harada disease.
    Curr Opin Ophthalmol. 2021;32:574-582.
    PubMed     Abstract available


  191. TRAN TM, Lee MS, McClelland CM
    Downbeat nystagmus: a clinical review of diagnosis and management.
    Curr Opin Ophthalmol. 2021;32:504-514.
    PubMed     Abstract available


  192. GRZYBOWSKI A, Shimada H, Nakashizuka H, Koerner J, et al
    Low-concentration povidone-iodine for the prevention of intraocular infections in ophthalmic surgery.
    Curr Opin Ophthalmol. 2021 Nov 1. pii: 00055735-900000000-98989.
    PubMed     Abstract available


  193. MUKHARESH L, Douglas VP, Chwalisz BK
    Chronic Relapsing Inflammatory Optic Neuropathy (CRION).
    Curr Opin Ophthalmol. 2021;32:521-526.
    PubMed    


    October 2021
  194. FORD RL, Frankfort BJ, Fleischman D
    Cerebrospinal fluid and ophthalmic disease.
    Curr Opin Ophthalmol. 2021 Oct 25. pii: 00055735-900000000-98999.
    PubMed     Abstract available


  195. VINOD K, Sidoti PA
    How glaucoma care changed for the better after the pandemic.
    Curr Opin Ophthalmol. 2021 Oct 25. pii: 00055735-900000000-98998.
    PubMed     Abstract available


  196. CIOCIOLA EC, Klifto MR
    Juvenile open angle glaucoma: current diagnosis and management.
    Curr Opin Ophthalmol. 2021 Oct 25. pii: 00055735-900000000-98997.
    PubMed     Abstract available


  197. HE X, Huang AS, Jeng BH
    Optimizing the ocular surface prior to cataract surgery.
    Curr Opin Ophthalmol. 2021 Oct 25. pii: 00055735-900000000-98996.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ophthalmology is free of charge.